Key result
Serial fluoroscopic evaluation of the Accufix 330-801 atrial lead in 80 patients detected no new retention wire fractures over 158 days, and existing fractures remained stable.
Why the study?
Does serial fluoroscopic screening detect new retention wire fractures in patients with the recalled Telectronics Accufix 330-801 atrial lead?
Observational (n=209)
Does serial fluoroscopic screening detect new retention wire fractures in patients with the recalled Telectronics Accufix 330-801 atrial lead?
Serial fluoroscopic screening of the recalled Accufix 330-801 atrial lead showed no new fractures over a 5-month period, though a significant learning curve exists for accurate initial interpretation.
Answers are grounded in this paper and cite their sources.
Short-term fluoroscopic stability in this small cohort supports continued monitoring; leaves open longer-term fracture risk and optimal screening frequency.
A recall of the Telectronics Accufix 330-801 atrial lead was issued in November 1994, because of fracture of the "J"-shaped retention wire. To assess the integrity of the retention wire, we have performed fluoroscopic screening on 209 patients with the Accufix 330-801 atrial lead in place. Cine films of all 135 patients originally classified as normal were reevaluated after the original screening. Eighty patients have undergone two serial fluoroscopic evaluations separated by 158 +/- 5.4 days. Nine retention wires originally classified as normal were reclassified as fracture without protrusion, and two were reclassified as fracture with protrusion when the original films were reevaluated. Eight of the 11 leads reclassified were screened during our first 2 days of fluoroscopic evaluation of this lead. Of the 80 patients who underwent a second fluoroscopic screening, 70 were initially classified as normal (9 of which were reclassified as described above), 1 fractured, and 9 indeterminate. There were no new fractures detected in this group, and the fractured retention wires did not appear to change during this observation period. We conclude that there is a definite learning curve associated with fluoroscopic evaluation of this lead, and continue to recommend that screening be performed by cardiologists experienced in fluoroscopic screening. Fractured retention wires remained stable in appearance during this observation time. No new retention wire fractures were detected; however, longer follow-up will be required before the incidence of retention wire fracture can be determined.
No takes yet. Share an insight, caveat, or question.
Lloyd et al. (1996) conducted an observational in Accufix 330-801 atrial lead in place (n=209). Serial fluoroscopic evaluation was evaluated on New retention wire fractures. Serial fluoroscopic evaluation of the Accufix 330-801 atrial lead in 80 patients detected no new retention wire fractures over 158 days, and existing fractures remained stable.
Synapse has enriched 10 related papers. Consider them for comparative context: